sur Asklepios Kliniken (isin : DE000A0ETLQ3)
Asklepios Group Reports Continued Positive Development in First Half of 2024
Asklepios Kliniken has announced successful financial results for the first half of 2024. The group's consolidated revenue soared to EUR 2,902.6 million, marking a 7.2% increase compared to the previous year's EUR 2,708.4 million. The net interim income after taxes for this period grew to EUR 74.1 million, significantly higher than last year's EUR 45.6 million.
The group treated 1,818,146 patients in the first six months, reflecting a steady demand for medical care. Investments also remained robust at EUR 150.5 million. Asklepios maintains a competitive position in Germany's evolving healthcare landscape, despite economic challenges.
With integrated cooperation with MEDICLIN and RHÖN, Asklepios continues to enhance its operational efficiency. CEO Joachim Gemmel praised the group's resilience and commitment to advancing medical quality and innovation. The future outlook remains cautiously optimistic amid regulatory and economic uncertainties.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Asklepios Kliniken